---
title: "Immix Biopharma terminates Richard Graydon employment"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293196093.md"
description: "Immix Biopharma terminated Richard Graydon's employment effective July 17, 2026. The departure is unrelated to his company activities and expected to have no material impact on business due to his short tenure."
datetime: "2026-07-20T10:06:54.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293196093.md)
  - [en](https://longbridge.com/en/news/293196093.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293196093.md)
generator: "portal-rs"
---

# Immix Biopharma terminates Richard Graydon employment

-   Immix Biopharma terminated Richard Graydon, effective July 17, 2026. \* Departure was described as unrelated to his activities at the company. \* Management expects no material impact on the business, citing Graydon’s short tenure. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immix Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-033829), on July 20, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [IMMX.US](https://longbridge.com/en/quote/IMMX.US.md)

## Related News & Research

- [Immix Biopharma publishes corporate presentation on NXC-201 BCMA CAR-T in relapsed/refractory AL amyloidosis](https://longbridge.com/en/news/295441199.md)
- [Immix Biopharma Q2 FY26 net loss widens to USD 11.56 million; G&A expense more than doubled to USD 7.12 million](https://longbridge.com/en/news/295278368.md)
- [Exmar announces availability of 2026 half-year results release](https://longbridge.com/en/news/296992548.md)
- [Eiffage announces availability of H1 2026 results report](https://longbridge.com/en/news/297066901.md)
- [IBA publishes H1 2026 results presentation](https://longbridge.com/en/news/297180350.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**